PHC Holdings Corporation (TSE 6523) is a global healthcare company with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Our subsidiaries, known collectively as PHC Group, include PHC Corporation, Ascensia Diabetes Care, Epredia, LSI Medience Corporation, Mediford, and Wemex. Together, these companies develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, life sciences and diagnostics. PHC Group's consolidated net sales in FY2022 were JPY 356.4 billion with global distribution of products and services in more than 125 countries and regions.